Metabolic activation of a pentafluorophenylethylamine derivative: Formation of glutathione conjugates in vitro in the rat

References

• Arttamangkul S, Bhalgat MK, Haugland RP, Diwu Z, Liu J, Klaubert DH, Haugland RP. 1999. 54Pentaflurobenzoylamino)fluorescein: A selective substrate for the determination of glutathione concentration and glutathione s-transferase activity. Analytical Biochemistry 269:410–417.
   PubMed Web of Science ®Google Scholar
• Baillie TA, Davis MR. 1993. Mass spectrometry in the analysis of glutathione conjugates. Biological Mass Spectrometry 22:319–325.
   PubMedGoogle Scholar
• Correia MA. 1995. Rat and human liver cytochromes P450 substrate and inhibitor specificities and functional markers. In: Ortiz PR, editor. P450: Structure, mechanism, and biochemistry. New York, NY: Plenum. pp 607–630.
   Google Scholar
• Deacon CF, Nauck MA, Mejer J, Hucking K, Ho1st JJ. 2000. Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. Journal of Clinical Endocrinology and Metabolism 85:3575–3581.
   PubMed Web of Science ®Google Scholar
• Den Besten C, Van Bladeren PJ, Duizer E, Vervoort J, Rietjens JMCM. 1993, Cytochrome P450-mediated oxidation of pentafluorophenol to tetrafluorobenzoquinones the primary reaction product. Chemical Research in Toxicology 6:674–680.
   PubMed Web of Science ®Google Scholar
• Edmonson S, Mastracchio A, Beconi M, Colwell LF Jr, Habulihaz B, He H, Kumar S, Leiting B, Lyons K, Mao A, Marsilio F, Patel RA, Wu JK, Zhu L, Thomberry NA, Webber AE, Pamee ER. 2004. Potent and selective proline amide derived dipeptidyl peptidase IV inhibitors. Bioorganic and Medicinal Chemistry Letters 14:5151–5155.
   PubMedGoogle Scholar
• Frankmoelle MP, Medina JC, Shan B, Narbut MR, Beckman H. 2000. Glutathione 5-transferase metabolism of the antineoplastic pentafluorophenylsulfonamide in tissue culture and mice. Drug Metabolism and Disposition 28:951–958.
   PubMedGoogle Scholar
• Hansen L, Deacon CF, Orskoy C, Holst JJ. 1999. Glucagon-like peptide-1-(7-36) amide is transformed to glucagon-like peptide-149-36) amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140:5356–5363.
   PubMed Web of Science ®Google Scholar
• Kitteringham NR, Kenna JG, Mclean C, Clarke JB, Park BK. 1992, Conjugation of dinitrofluorobenzene to plasma proteins in vivo in the rat. Drug Metabolism and Disposition 20:625–631.
   PubMed Web of Science ®Google Scholar
• LeCluyse EL, Ahlgren-Beckendorf JA, Carroll K, Parkinson A, Johnson J. 2000. Regulation of glutathione 5-transferase enzymes in primary cultures of rat hepatocytes maintained under various matrix configurations. Toxicology In Vitro 14:101–115.
   PubMedGoogle Scholar
• Low LK, Castagnoli N Jr. 1982. Metabolic changes of drugs and related organic compounds. In: Doerge RF, editor. Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry. Philadelphia, PA: J. B. Lippincott. pp 60–64.
   Google Scholar
• Mentlein R. 1999. Dipeptidyl-peptidase IV (CD26)—role in the inactivation of regulatory peptides. Regulatory Peptides 85:9–24.
   Google Scholar
• Monks TJ. 1995, Modulation of quinol/quinone-thioether toxicity by intramolecular detoxication. Drug Metabolism Review 27:93–106.
   PubMed Web of Science ®Google Scholar
• Monks TJ, Lau SS. 1997. Biological reactivity of polyphenolic-glutathione conjugates. Chemical Research in Toxicology 10:1296–1313.
   PubMed Web of Science ®Google Scholar
• Mutch P, Dear G, Ismail I. 2001. Formation of a defluorinated metabolite of a quinoxaline antiviral drug catalysed by human cytochrome P450 1A2. Journal of Pharmacy and Pharmacology 53:403–408.
   PubMed Web of Science ®Google Scholar
• Newton DJ, Wang RW, Lu AYH. 1995. Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition 23:154–158.
   Google Scholar
• Pang JM, Zaleski J, Kauffman FC. 1997. Toxicity of allyl alcohol in primary cultures of freshly isolated and cryopreserved hepatocytes maintained on hydrated collagen gels. Toxicology and Applied Pharmacology 142:87–94.
   PubMed Web of Science ®Google Scholar
• Park B, Kitteringham NR. 1994. Effects of fluorine substitution on drug metabolism. Drug Metabolism Review 26:605–643.
   PubMed Web of Science ®Google Scholar
• Park B, Kitteringham N, O'Neill P. 2001. Metabolism of fluorine-containing drugs. Annual Review of Pharmacology and Toxicology 41:443–470.
   PubMed Web of Science ®Google Scholar
• Pitot HC III, Dragan YP. 2001. Chemical carcinogenesis. In: Klaassen CD, editor. Casarett and Doull's toxicology: The basic science and poisons. New York, NY: McGraw-Hill. pp 241–319.
   Google Scholar
• Pospisilik JA, Hinke SA, Pederson RA, Hoffman T, Rosche F, Schlenzig D, Glund K, Heiser U, McIntosh CH, Demuth H. 2001. Metabolism of glucagon by dipeptidyl peptidase IV (CD26). Regulated Peptides 96:133-141. Raucy JL, Lasker JM. 1991. Isolation of P450 enzymes from human liver. Methods in Enzymology 206:577–587.
   Google Scholar
• Rietjens IMCM, Besten CD, Hanzlik RP, Bladeren PJV. 1997. Cytochrome P450-catalysed oxidation of halobenzene derivatives. Chemical Research in Toxicology 10:629–635.
   PubMed Web of Science ®Google Scholar
• Rietjens IMCM, Vervoort J. 1992. A new hypothesis for the mechanism for Cytochrome P450 dependent aerobic conversion of hexahalogenated benzenes to pentahalogenated phenols. Chemical Research in Toxicology 5:10–19.
   PubMed Web of Science ®Google Scholar
• Samuel K, Yin W, Stearns RA, Tang YS, Chaudhary AG, Jewell JP, Lanza T Jr, Lin LS, Hagmann WK, Evans DC, Kumar S. 2003. Addressing the metabolic activation of new leads in drug discovery: A case study using ion-trap mass spectrometry and tritium labeling techniques. Journal of Mass Spectrometry 38:211–221.
   PubMed Web of Science ®Google Scholar
• Schmidt W, Siegel E, Ebert R, Creuzfeldt W. 1986. N-terminal tyrosine-alanine is required for the insulin releasing activity of glucose-dependent insulinotropic polypeptide (GIP). European Journal of Clinical Investigation 16:A9.
   Google Scholar
• Vermeulen NPE. 1996. Role of drug metabolism in chemical toxicity. In: Ioannides C, editor. Cytochromes P450 metabolic and toxicological aspects. Boca Raton, FL: CRC Press. pp 29–53.
   Google Scholar
• Wiedeman PE, Trevillyan JM. 2003. Dipeptidyl peptidase IV inhibitors for the treatment of impaired glucose tolerance and type 2 diabetes. Current Opinion in Investigational Drugs 4:412–420.
   PubMedGoogle Scholar
• Willson RA, Hart J, Hall T, Vincent SH. 1990. Inverse relationship between total glutathione 5-transferase content and bile acid release in isolated hepatocytes from untreated, phenobarbital-pretreated and hypothyroid rats. Pharmacology and Toxicology 66:121–127.
   Google Scholar